These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 8645033

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
    Hayashi T, Takahashi T, Mihara M, Shimizu H, Tsukuda H, Kobayashi T, Adachi M, Hinoda Y, Aoki S, Mori M, Tsujisaki M, Imai K.
    Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532
    [No Abstract] [Full Text] [Related]

  • 3. Low-dose epirubicin in combination with cyclophosphamide, vinblastine and prednisone (mini-CEOP) for the treatment of aggressive non-Hodgkin's lymphoma in elderly patients.
    Veneri D, Zanetti F, Franchini M, Krampera M, Pizzolo G.
    Haematologica; 2002 Nov; 87(11):ELT43. PubMed ID: 12414364
    [No Abstract] [Full Text] [Related]

  • 4. Cyclophosphamide, epirubicin, vincristine and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
    Comella P, Abate G, Fiore M, Di Finizio G, Polverino W, Muto P, Zarrilli D.
    Haematologica; 1988 Nov; 73(6):509-12. PubMed ID: 3148514
    [No Abstract] [Full Text] [Related]

  • 5. A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial.
    Hertzberg M, Matthews JP, Stone JM, Dubosq MC, Grigg A, Ellis D, Benson W, Browett P, Horvath N, Januszewicz H, Abdi E, Green M, Bonaventura A, Marlton P, Cannell P, Wolf M, ALLG.
    Am J Hematol; 2014 May; 89(5):536-41. PubMed ID: 24481640
    [Abstract] [Full Text] [Related]

  • 6. Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas.
    Gerhartz HH, Engelhard M, Brittinger G, Schlimok G, Thiel E, Huber C, Emmerich B, Schadek C, Brandmaier R, Stern AC.
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):25-8. PubMed ID: 7528447
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
    Alliot C.
    J Clin Oncol; 2005 Jul 20; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL). The Central Lymphoma Group.
    Smith GM, Child JA, Cullen MH, Bailey NP, Woodruffe CM, Fletcher J, Earl H, Barnard D.
    Hematol Oncol; 1996 Dec 20; 14(4):193-201. PubMed ID: 9267465
    [Abstract] [Full Text] [Related]

  • 11. [Effect of granulocyte colony-stimulating factor after chemotherapy with CHOP in patients with non-Hodgkin's lymphoma and HIV infection].
    Navarro JT, Ribera JM, Gómez-Espuch J, Feliu E.
    Med Clin (Barc); 1996 Jun 15; 107(3):118-9. PubMed ID: 8754503
    [No Abstract] [Full Text] [Related]

  • 12. [Comparison of two multi-drug chemotherapy regimens based on mitoxantrone and epirubicin in 44 patients with non-Hodgkin's lymphoma].
    Gao HR.
    Zhonghua Zhong Liu Za Zhi; 1991 Jul 15; 13(4):287-90. PubMed ID: 1806350
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
    Imura H, Ito N, Shirakawa S, Sobue R, Maruyama F, Kojima H, Shinkai K, Matsui T, Ino T, Shimizu K.
    Rinsho Ketsueki; 1988 May 15; 29(5):688-93. PubMed ID: 3216495
    [No Abstract] [Full Text] [Related]

  • 15. [High-dose biweekly CHOP chemotherapy with granulocyte colony-stimulating factor support for patients with aggressive non-Hodgkin lymphoma].
    Taguchi H, Shishido T, Niitsu N, Hiraoka A, Kageyama T, Kanamaru A, Ogawa M.
    Gan To Kagaku Ryoho; 1998 Mar 15; 25(4):523-9. PubMed ID: 9530358
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic strategies in intermediate grade lymphomas in elderly patients. The Italian Multiregional non Hodgkin's Lymphoma Study Group (IMRNHLSG).
    Bertini M.
    Hematol Oncol; 1993 Mar 15; 11 Suppl 1():52-8. PubMed ID: 7683623
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.